About: MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.40 (+0.29%)
MNOV NASDAQ MediciNova Inc
MediciNova Inc share price
MNOV price activity
Last Price
$1.400
Change (24hr)
0.00 USD (0.29%)
Volume
16.08K
Volume (4w avg)
-
Open
$1.42
Day Range
$1.38 - $1.42
Previous Close
$1.40
Last Trade
30 Oct, 6:25 pm GMT+0
Delayed
30 Oct, 6:25 pm GMT+0
MNOV price performance
Delayed
30 Oct, 6:25 pm GMT+0
MNOV Market Signals